Merck – SRK BHARAT

Moderna and Merck Advance Personalized mRNA Cancer Vaccine Trials as Shares Rise

Biotechnology firm Moderna and pharmaceutical giant Merck announced significant clinical progress in the development of their experimental messenger RNA cancer vaccine. The innovative treatment aims to target individual patient tumors…

srkanalytics.srk@gmail.com August 20, 2026

Business

Moderna Stock Surges as Melanoma Vaccine Trial Shows Landmark Moment

Biotechnology firm Moderna saw a significant surge in its stock value following the release of highly anticipated clinical trial results for a personalized messenger RNA melanoma vaccine. Developed in partnership…

srkanalytics.srk@gmail.com August 20, 2026

Health

Moderna and Merck Announce Breakthrough Results in Experimental Melanoma Vaccine Trial

Biotechnology firm Moderna and pharmaceutical giant Merck announced groundbreaking clinical trial results this week, revealing that their experimental messenger RNA (mRNA) cancer vaccine significantly reduces the risk of melanoma recurrence…

srkanalytics.srk@gmail.com August 20, 2026

Health

Merck Secures $5 Generic HIV Prevention Pill Deal for Africa and India, Leaving Latin America’s Access Uncertain

Global pharmaceutical leader Merck has entered into voluntary licensing agreements with generic drug manufacturers across Africa and India to produce affordable versions of its novel H.I.V. prevention pill, targeting prices…

srkanalytics.srk@gmail.com July 25, 2026